For the Quarter Ending December 2025
North America
• In the USA, the Glucosamine Price Index rose by 1.88% quarter-over-quarter, driven by feedstock constraints.
• The average Glucosamine price for the quarter was approximately USD 7955.00/MT, per reported quarterly calculations.
• Glucosamine Spot Price tightened after limited prompt allocations from import qualification, prompting higher buyer bids.
• Glucosamine Price Forecast indicates modest upside into early year amid seasonal stocking and constrained imports.
• Glucosamine Production Cost Trend rose due to crustacean-shell feedstock price increases and reduced domestic output.
• Glucosamine Demand Outlook stayed constructive as nutraceutical and pet sectors increased restocking ahead of year-end.
• Glucosamine Price Index moves reflected inventory digestion, downstream procurement pacing, and stable logistics without disruptions.
• Suppliers moderated offers; exporters balanced competitive pricing against tightening feedstock and compliance-driven qualified import constraints.
Why did the price of Glucosamine change in December 2025 in North America?
• Feedstock shortages and higher crustacean-shell costs increased domestic processing expenses and tightened output availability further.
• FDA compliance constraints limited qualified imports, reducing prompt cargo availability and lifting FOB bids materially.
• End-market restocking by nutraceutical and pet sectors for year-end increased procurement urgency and spot demand.
APAC
• In China, the Glucosamine Price Index rose by 3.73% quarter-over-quarter, supported by steady export demand and tighter inventories.
• The average Glucosamine price for the quarter was approximately USD 4899.33/MT delivered on export FOB terms during the quarter.
• Glucosamine Spot Price rose modestly on regular inquiries, keeping the Price Index on firm trajectory.
• Glucosamine Production Cost Trend stayed subdued as chitin abundance and lower acid costs prevented pressure.
• Glucosamine Demand Outlook remains cautiously positive as nutraceutical restocking and seasonal orders modestly support pricing.
• Glucosamine Price Forecast suggests firming into early 2026, reflecting steady export flows and controlled inventories.
• Low warehouse stocks heightened sensitivity of the Glucosamine Price Index to incremental overseas buying interest.
• Qingdao port efficiency and stable freight rates prevented transport disruptions, preserving Glucosamine Price Index stability.
Why did the price of Glucosamine change in December 2025 in APAC?
• Export demand steadiness and reduced inventories increased procurement urgency, nudging prices higher in December 2025.
• Stable chitin supply and slightly lower hydrochloric acid costs tempered cost-push, keeping manufacturing margins supportive.
• Smooth Qingdao logistics and unchanged freight rates prevented transport shocks, maintaining steady export FOB competitiveness.
Europe
• In Europe, the Glucosamine Price Index rose modestly quarter-over-quarter, reflecting steady import demand and gradual inventory normalization.
• The average Glucosamine price for the quarter was approximately USD 5,250.00/MT, based on CFR Northwest Europe assessments.
• Glucosamine Spot Prices edged higher, as distributors replenished stocks selectively following steady nutraceutical offtake.
• The Glucosamine Production Cost Trend remained largely stable, as upstream feedstock movements were neutral and exporters avoided aggressive repricing.
• Glucosamine Demand Outlook stayed cautiously supportive, with nutraceutical brands maintaining baseline procurement for joint-health formulations.
• The Glucosamine Price Forecast indicated mild firmness, supported by controlled inventories and steady import programs into early 2026.
• Importer stock levels declined to near-average coverage, enhancing sensitivity of the Glucosamine Price Index to incremental buying.
• Port operations across key European hubs remained fluid, preventing logistical disruptions and sustaining stable landed pricing.
Why did the price of Glucosamine change in December 2025 in Europe?
• Gradual inventory drawdowns increased replenishment activity, lending support to Glucosamine prices during December.
• Stable upstream costs limited discounting behavior among exporters, allowing prices to firm modestly.
• Smooth port operations and predictable import flows maintained supply continuity, preventing sharp volatility while supporting incremental price gains.
For the Quarter Ending September 2025
North America
• In USA, the Glucosamine Price Index fell by 2.13% quarter-over-quarter, driven by cautious downstream procurement.
• The average Glucosamine price for the quarter was approximately USD 7808.33/MT, reported by export assessments.
• Steady exports and balanced inventories supported Glucosamine Spot Price stability despite procurement from downstream formulators.
• Short-term Glucosamine Price Forecast indicates gradual strengthening as seasonal restocking improves demand without supply disruptions.
• Stable raw material availability kept Glucosamine Production Cost Trend subdued, limiting upward pressure on offers.
• Inventory drawdowns and seasonal demand supported Glucosamine Demand Outlook heading into early fourth quarter momentum.
• Export enquiries rose ahead of winter production, reinforcing the Glucosamine Price Index trajectory toward gains.
• Major producers reported uninterrupted operations, keeping supply consistent and validating Glucosamine Spot Price resilience levels.
Why did the price of Glucosamine change in September 2025 in North America?
• Seasonal restocking increased procurement urgency, tightening available inventories and supporting upward price momentum in September.
• Uninterrupted production and stable feedstock supplies prevented cost shocks, keeping Glucosamine availability steady throughout September.
• Muted international buying during quarter reduced export volumes, exerting downward pressure on Glucosamine Price Index.
APAC
• In China, the Glucosamine Price Index fell by 11.33% quarter-over-quarter, driven by subdued export demand.
• The average Glucosamine price for the quarter was approximately USD 4723.33/MT, reflecting weak buyer restocking activity.
• Glucosamine Spot Price softened as suppliers reduced offers to clear elevated export inventories amid muted uptake.
• Glucosamine Price Forecast suggests modest firming into Q4 if seasonal replenishment sustains and inventories normalize.
• Glucosamine Production Cost Trend remained benign due to stable feedstock and energy benchmarks limiting upward pressure.
• Glucosamine Demand Outlook improved late September with formulators replenishing for winter production and promotional cycles.
• Glucosamine Price Index volatility reflected longer bearish pressures abating as export contracts and e-commerce sales firmed.
• Major Chinese producers maintained stable operations, supplying consistent volumes despite softer order flows and elevated stocks.
Why did the price of Glucosamine change in September 2025 in APAC?
• Elevated export inventories pressured offers as suppliers cut prices to maintain throughput and reduce stock.
• Stable feedstock and energy costs kept Glucosamine Production Cost Trend flat, removing upward cost-push support.
• Seasonal restocking and stronger formulators' procurement in September tightened spot availability, prompting modest price recovery.
Europe
• In Europe, the Glucosamine Price Index fell by ~8.5% quarter-over-quarter, pressured by softer export enquiries and ample imported volumes.
• The average Glucosamine price for the quarter was approximately USD 5,000.00/MT (conservative estimate due to limited consolidated transaction data).
• Glucosamine Spot Price softened as distributors and online retailers delayed restocking and cleared higher-than-normal inventories.
• Glucosamine Price Forecast suggests modest firming into Q4 if winter promotional buying and pharmaceutical/OTC replenishment pick up.
• Glucosamine Production Cost Trend remained muted with stable feedstock and moderate energy costs, limiting upward pressure on offers.
• Glucosamine Demand Outlook is cautious but shows pockets of improvement from supplement formulators preparing for seasonal demand.
• Glucosamine Price Index volatility reflected cross-border import flows, currency (EUR/USD) moves, and uneven purchasing across EU markets.
• European packers and distributors maintained steady operations, supplying volumes from inventories which contained sharp price moves.
Why did the price of Glucosamine change in September 2025 in Europe?
• Elevated inventories and weaker immediate procurement reduced distributor buying urgency, driving spot offers lower.
• Stable feedstock and energy costs kept production-cost pressure limited, so price changes were demand-led rather than cost-driven.
• Improved seasonal/formulator restocking late in the quarter tightened prompt availability slightly, supporting modest stabilization.
For the Quarter Ending June 2025
North America
• The Glucosamine Spot Price in the U.S. export market (FOB New Jersey) displayed a mild downtrend through Q2 2025 and closed at USD 7,560/MT in the fourth week of June. The price trend marked a 0.40% decline which was influenced by persistent weak demand both domestically and internationally.
• The Glucosamine Price Index recorded mixed movements through Q2—starting with a 1.04% decline in April then showing a 0.61% increase in mid-May and reverting to softness again in June. These modest fluctuations reflect cautious procurement amid stable availability.
• Why did the price change in July 2025?
In July, the price slightly declined further due to continued cautious buying from overseas pharmaceutical buyers with abundant inventories that left no room for speculative upticks.
• The Glucosamine Production Cost Trend remained stable across U.S. facilities during Q2 with no reported supply disruptions. Manufacturing units continued running at full capacity which was supported by consistent raw material access and efficient plant operations.
• Inventory drawdowns in early Q2 were slow, as many buyers utilized pre-stocked materials from Q1. This limited fresh procurement and kept the pricing environment competitive.
• The Glucosamine Demand Outlook remained neutral to weak. While routine purchases by pharmaceutical and nutraceutical players continued, there was no significant spike to stimulate a price rebound.
• Competitive East Asian imports—particularly from China—exerted price pressure in the U.S. market. Tariff-related uncertainties also made importers more price-sensitive.
• Freight and port operations across New Jersey and East Coast hubs remained efficient, with no logistical disruptions reported throughout the quarter.
• U.S. exporters adopted strategic pricing moderation to preserve market share against competing global suppliers, especially with lower cost offers arriving from Asia.
Asia Pacific
• The Glucosamine Spot Price in China (FOB Qingdao) showed a mixed Q2 trend, peaking in the first week of June with a 1.28% rise and retreating by 0.93% to USD 5,350/MT in the fourth week due to oversupply.
• The Glucosamine Price Index for Q2 in Asia Pacific reflected price firmness in May and early June, before slipping late in the quarter under elevated inventories and routine but unremarkable demand.
• Why did the price change in July 2025?
The price in July continued to soften slightly due to carryover inventories, cautious procurement behaviour among Southeast Asian buyers, and efforts by Chinese suppliers to clear stock ahead of Q3 cycles.
• The Glucosamine Production Cost Trend stayed relatively steady throughout Q2 in China, with full operational capacity and no raw material bottlenecks. Cost management was supported by stable chitin feedstock availability.
• Downstream demand, especially from the nutraceutical and pharmaceutical sectors, stayed consistent, yet lacked the scale to drive bullish price movement.
• The Glucosamine Demand Outlook across the Asia Pacific region remained stable but plateaued, with joint health supplement demand strong, yet incremental growth limited.
• Inventory turnover was healthy through early June, but later weeks saw some saturation, leading to price corrections as suppliers aimed to stimulate restocking.
• Export channels remained uninterrupted, and Qingdao port operations flowed seamlessly, ensuring no logistical friction for international buyers.
• Forward contracts from South Korea, Japan, and Southeast Asia supported stability in early Q2, but by late June, new inquiries had slowed, mirroring cautious end-user sentiment.
Europe
• The Glucosamine Spot Price across major European ports (e.g., Rotterdam and Hamburg) likely mirrored global trends in Q2 2025, beginning with mild softness in April, moving into neutral territory by May, and weakening slightly by late June due to elevated inventories.
• The Glucosamine Price Index in Europe likely followed a narrow range trend during the quarter, impacted by surplus stocks, modest procurement cycles, and competition from lower-cost Asian imports.
• Why did the price change in July 2025?
Prices in July dipped marginally due to muted demand from the supplement industry and sustained inflow of competitively priced Asian cargoes. Buyers continued to rely on pre-booked inventory.
• The Glucosamine Production Cost Trend remained neutral in Europe, with low domestic production activity and a high dependency on imports. Processing and distribution costs remained stable due to efficient intra-EU logistics.
• European buyers showed preference for spot purchases rather than long-term contracts during Q2, further indicating caution and tight inventory management.
• The Glucosamine Demand Outlook in Europe remained steady yet unspectacular, with regular consumption in dietary supplement formulations and pharma-grade Glucosamine demand holding firm.
• Import flows from China and India fulfilled most regional needs, with no major disruptions in customs or cargo handling reported.
• Demand from Germany, France, and the UK remained relatively stable, though price-sensitive buyers delayed restocking in June awaiting potential Q3 corrections.
• Overall market sentiment across Europe reflected a cautious outlook, with inventory-led procurement strategies, stable cost structures, and subdued momentum in new order placements.
For the Quarter Ending March 2025
North America
In the first quarter of 2025, the average price of Glucosamine in the North American market increased by 0.96% from concluding quarter of 2024. This moderate rise was largely supported by steady procurement activity from pharmaceutical and nutraceutical companies. The demand for joint health supplements and wellness products remained consistent during the colder months of January and February. The consumers relied on Glucosamine supplements and focused more on immunity and joint care in winter.
The seasonal shift from winter to early spring also influenced purchasing trends and resulted in buyers ensuring a stable inventory level to avoid supply disruptions. Additionally, tariff measures introduced during the quarter on certain imports strengthened local supply chains and encouraged domestic procurement. This scenario offered suppliers an opportunity to maintain firm pricing.
Logistics and transportation conditions in the region remained stable throughout the quarter, further supporting balanced supply dynamics. The demand from downstream sectors like personal care and fortified food products also contributed to this price trend. The overall Glucosamine market behaviour in first quarter of 2025 reflected cautious yet strategic procurement by buyers who aligned their purchases with seasonal demand patterns and policy adjustments.
Asia Pacific
The Asia Pacific Glucosamine market experienced a quarterly average price increase of 0.50% in first quarter of 2025. The price movement was steady, supported by moderate demand from pharmaceutical and nutraceutical industries across the region. A key factor influencing the market was the seasonal transition from winter to spring, which typically affects the consumption patterns of Glucosamine supplements and joint care products.
The Lunar Year holiday celebrations in February resulted in brief market closures in the APAC region and post-holiday demand recovery played a role in maintaining price stability. Glucosamine suppliers strategically managed inventories, avoiding oversupply situations while responding to consistent inquiries from buyers looking to replenish stocks ahead of the new production cycles. Demand from downstream sectors like wellness drinks and fortified functional foods remained steady but not aggressively high.
Smooth logistics operations and stable transportation costs also contributed to the balanced price trend during the quarter. Overall, the market showed a cautious but healthy pace in first quarter of 2025, with procurement aligning closely with seasonal shifts and supplier’s pricing strategies to avoid volatility.
Europe
In Europe, the Glucosamine prices followed a moderately stable trend during the first quarter of 2025 and mirrored the measured increases seen in other key markets. While the Glucosamine market varied from country to country, but the broader behaviour aligned closely with global trends, particularly those from export regions like North America and Asia Pacific.
Pharmaceutical and nutraceutical demand remained steady across major economies with Glucosamine supplements and wellness-focused products maintaining regular offtake. Seasonal transitions from colder months to early spring supported stable downstream consumption, especially in personal care and functional food products. Glucosamine suppliers in Europe managed inventories strategically and ensured market balance to avoid surplus situations.
Transportation and logistics networks performed smoothly throughout the first quarter and supported uninterrupted trade flows. Glucosamine buyers showed careful procurement behaviour and adjusted purchases based on anticipated production cycles and seasonal consumption needs. Overall, the European Glucosamine market displayed a calm and steady tone which was shaped by consistent demand and supplier strategies aligned with broader international market patterns.
